Baxter and New York-Presbyterian/Weill Cornell Announce 18-Month Data from Phase II Study of GAMMAGARD in Patients with Alzheimer's Disease http://www.marketwatch.com/story/baxter-and-new-york-presbyterianweill-cornell-announce-18-month-data-from-phase-ii-study-of-gammagard-in-patients-with-alzheimers-disease-2010-04-13?reflink=MW_news_stmp